UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview

Clinical pharmacology and therapeutics, 1986-08, Vol.40 (2), p.125-133

Drayer, Dennis E

1986

Volltextzugriff (PDF)

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome

The New England journal of medicine, 1978-05, Vol.298 (21), p.1157

1978

Volltextzugriff (PDF)

Alteration of drug-protein binding in renal disease

Clinical pharmacokinetics, 1984-01, Vol.9 Suppl 1 (Supplement 1), p.18-26

1984

Volltextzugriff (PDF)

Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals

The American journal of medicine, 1984-06, Vol.76 (6), p.989-998

1984

Volltextzugriff (PDF)

Stereoselective renal tubular secretion of quinidine and quinine

Clinical pharmacology and therapeutics, 1986-11, Vol.40 (5), p.511-517

1986

Volltextzugriff (PDF)

Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy

The New England journal of medicine, 1983-11, Vol.309 (20), p.1213

1983

Volltextzugriff (PDF)

Hydromorphone levels and pain control in patients with severe chronic pain

Clinical pharmacology and therapeutics, 1988-10, Vol.44 (4), p.376-382

1988

Volltextzugriff (PDF)

On the use of drugs administered as racemates

Clinical pharmacology and therapeutics, 1987-10, Vol.42 (4), p.364-364

Drayer, Dennis E

1987

Volltextzugriff (PDF)

Clinical consequences of polymorphic acetylation of basic drugs

Clinical pharmacology and therapeutics, 1977-09, Vol.22 (3), p.251-258

1977

Volltextzugriff (PDF)

Clinical Consequences of the Lipophilicity and Plasma Protein Binding of Antiarrhythmic Drugs and Active Metabolites in Man

Annals of the New York Academy of Sciences, 1984-12, Vol.432 (1), p.45-56

DRAYER, DENNIS E.

1984

Volltextzugriff (PDF)

Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages

Clinical pharmacology and therapeutics, 1983-07, Vol.34 (1), p.14-22

1983

Volltextzugriff (PDF)

Aging and renal clearance of procainamide and acetylprocainamide

Clinical pharmacology and therapeutics, 1980-12, Vol.28 (6), p.732-735

1980

Volltextzugriff (PDF)

Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide

The New England journal of medicine, 1979-12, Vol.301 (25), p.1382

1979

Volltextzugriff (PDF)

THE EARLY HISTORY OF STEREOCHEMISTRY: FROM THE DISCOVERY OF MOLECULAR ASYMMETRY AND THE FIRST RESOLUTION OF A RACEMATE BY PASTEUR TO THE ASYMMETRICAL CHIRAL CARBON OF VAN'T HOFF AND LE BEL1

Clinical research and regulatory affairs, 2001, Vol.18 (3), p.181-203

Drayer, Dennis E.

2001

Volltextzugriff (PDF)

Age and renal clearance of cimetidine

Clinical pharmacology and therapeutics, 1982-01, Vol.31 (1), p.45-50

1982

Volltextzugriff (PDF)

THE EARLY HISTORY OF STEREOCHEMISTRY: FROM THE DISCOVERY OF MOLECULAR ASYMMETRY AND THE FIRST RESOLUTION OF A RACEMATE BY PASTEUR TO THE ASYMMETRICAL CHIRAL CARBON OF VAN'T HOFF AND LE BEL

Clinical research and regulatory affairs, 2001-01, Vol.18 (3), p.181-203

Drayer, Dennis E.

2001

Volltextzugriff (PDF)

Renal injury in patients with rheumatoid arthritis treated with gold

Clinical pharmacology and therapeutics, 1980-08, Vol.28 (2), p.216-222

1980

Volltextzugriff (PDF)

Pubertal changes in net renal tubular secretion of digoxin

Clinical pharmacology and therapeutics, 1984-04, Vol.35 (4), p.438-446

1984

Volltextzugriff (PDF)

Lipophilicity, Hydrophilicity, and the Central Nervous System Side Effects of Beta Blockers

Pharmacotherapy, 1987-01, Vol.7 (4), p.87-91

Drayer, Dennis E.

1987

Volltextzugriff (PDF)

Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in man

Therapeutic drug monitoring, 1988, Vol.10 (1), p.1-7

DRAYER, D. E

1988

Volltextzugriff (PDF)

Microsomal hydroxylation as measured by pentobarbital elimination in patients with idiopathic systemic lupus erythematosus

Clinical pharmacology and therapeutics, 1982-08, Vol.32 (2), p.195-200

1982

Volltextzugriff (PDF)

Antiarrhythmic activity of p-hydroxy-N-(2-diethylaminoethyl)benzamide (the p-hydroxy isostere of procainamide) in dogs and mice

Journal of medicinal chemistry, 1977-02, Vol.20 (2), p.270-274

1977

Volltextzugriff (PDF)

Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations

Drugs (New York, N.Y.), 1982-12, Vol.24 (6), p.519-542

Drayer, D E

1982

Volltextzugriff (PDF)

Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure

Clinical pharmacokinetics, 1976-01, Vol.1 (6), p.426-443

Drayer, D E

1976

Volltextzugriff (PDF)

Antibodies: a rich source of novel chemical agents for pharmacological studies

Trends in pharmacological sciences (Regular ed.), 1988-10, Vol.9 (10), p.373-375

1988

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(58)
Buchkapitel
(1)

Sprache

Englisch
(59)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(43)
Humans
(41)
Pharmacology & Pharmacy
(25)
Adult
(21)
Male
(20)
Middle Aged
(20)
Aged
(17)
Female
(15)
Biological And Medical Sciences
(11)
Medical Sciences
(10)
Pharmaceutical Preparations - Metabolism
(9)
Acetylation
(8)
Animals
(8)
Kinetics
(8)
Protein Binding
(8)
Pharmacology. Drug Treatments
(7)
Procainamide - Metabolism
(7)
Biotransformation
(6)
General & Internal Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome

Alteration of drug-protein binding in renal disease

Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals

Stereoselective renal tubular secretion of quinidine and quinine

Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy

Hydromorphone levels and pain control in patients with severe chronic pain

On the use of drugs administered as racemates

Clinical consequences of polymorphic acetylation of basic drugs

Clinical Consequences of the Lipophilicity and Plasma Protein Binding of Antiarrhythmic Drugs and Active Metabolites in Man

Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages

Aging and renal clearance of procainamide and acetylprocainamide

Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide

THE EARLY HISTORY OF STEREOCHEMISTRY: FROM THE DISCOVERY OF MOLECULAR ASYMMETRY AND THE FIRST RESOLUTION OF A RACEMATE BY PASTEUR TO THE ASYMMETRICAL CHIRAL CARBON OF VAN'T HOFF AND LE BEL1

Age and renal clearance of cimetidine

THE EARLY HISTORY OF STEREOCHEMISTRY: FROM THE DISCOVERY OF MOLECULAR ASYMMETRY AND THE FIRST RESOLUTION OF A RACEMATE BY PASTEUR TO THE ASYMMETRICAL CHIRAL CARBON OF VAN'T HOFF AND LE BEL

Renal injury in patients with rheumatoid arthritis treated with gold

Pubertal changes in net renal tubular secretion of digoxin

Lipophilicity, Hydrophilicity, and the Central Nervous System Side Effects of Beta Blockers

Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in man

Microsomal hydroxylation as measured by pentobarbital elimination in patients with idiopathic systemic lupus erythematosus

Antiarrhythmic activity of p-hydroxy-N-(2-diethylaminoethyl)benzamide (the p-hydroxy isostere of procainamide) in dogs and mice

Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations

Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure

Antibodies: a rich source of novel chemical agents for pharmacological studies

Suchergebnisse filtern